ArticleSAGE open medical case reports2025
Therapeutic hyaluronidase to provide optimal aesthetic outcomes: A case report and call to action.
Article in SAGE open medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With hyaluronic acid injectable treatments becoming increasingly popular, more patients are presenting with pre-existing hyaluronic acid creating a poor cosmetic effect, requiring subsequent dissolving with hyaluronidase. We sought to characterize the clinical features and demographics of patients receiving therapeutic hyaluronidase electively and not in the context of an adverse event. We retrospectively reviewed the charts of patients receiving therapeutic hyaluronidase in two aesthetic dermatology practices from 2020 to 2024. There were 35 patients, ranging in age from 23 to 74 years. Fifty-seven percent of patients sought consultation for further injectable treatments and were unaware of the negative impact of their prior hyaluronic acid. Our data highlight the necessity of considering therapeutic hyaluronidase during an aesthetic consultation. Practitioners who seek to provide patients with the most optimal, natural, and balanced cosmetic outcomes must both recognize the signs of excess or poorly placed hyaluronic acid and be comfortable in administering treatment with hyaluronidase.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.